SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 144 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,079,000 | -2.0% | 46,646 | +11.1% | 0.00% | – |
Q2 2023 | $1,101,000 | +54.4% | 41,987 | +51.7% | 0.00% | – |
Q1 2023 | $713,000 | -5.2% | 27,677 | -4.5% | 0.00% | – |
Q4 2022 | $752,000 | -0.8% | 28,967 | +9.0% | 0.00% | – |
Q3 2022 | $758,000 | +22.5% | 26,581 | +5.8% | 0.00% | – |
Q2 2022 | $619,000 | -58.6% | 25,134 | -5.0% | 0.00% | – |
Q1 2022 | $1,494,000 | -7.2% | 26,465 | +1.8% | 0.00% | – |
Q4 2021 | $1,610,000 | +61.6% | 25,986 | +65.5% | 0.00% | – |
Q3 2021 | $996,000 | +303.2% | 15,702 | +425.3% | 0.00% | – |
Q2 2021 | $247,000 | +6.9% | 2,989 | -4.9% | 0.00% | – |
Q1 2021 | $231,000 | +260.9% | 3,142 | +259.9% | 0.00% | – |
Q4 2020 | $64,000 | +88.2% | 873 | +21.6% | 0.00% | – |
Q3 2020 | $34,000 | +9.7% | 718 | -4.0% | 0.00% | – |
Q2 2020 | $31,000 | +55.0% | 748 | +0.3% | 0.00% | – |
Q1 2020 | $20,000 | – | 746 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |